Florida-distributed gummy supplement brand discloses ingredient origins, manufacturing standards, and consumer safety considerations for 2026Lakeland, FL, June 25, 2026 (GLOBE...
ASHEVILLE, N.C., June 25, 2026 (GLOBE NEWSWIRE) -- In the ongoing development of its comprehensive maternal health platform, Aeroflow Health,...
ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and...
FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand...
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy, a telehealth platform that connects patients with licensed healthcare providers,...
The article reviews proposed reimbursement policy changes and their potential impact on lactation services, provider participation, and patient access.NASHVILLE, Tenn.,...
Eligibility extends to patients with unresectable or metastatic synovial sarcoma who have received prior chemotherapy and meet HLA and MAGE-A4...
Nuvo's RHTP support package simplifies the RHTP application processAVENTURA, Fla., June 18, 2026 /PRNewswire/ -- With the October 30, 2026,...
$720,000 commitment powers mobile clinic delivering prenatal, postpartum and mental health services to Southeast MissouriOriginally published on CVS Health Company...
PHILADELPHIA, June 16, 2026 /PRNewswire/ -- The Pew Charitable Trusts today announced the 2026 class of the Pew Latin American...
The new feature inside the FDA-cleared app connects sleep and cycle insights in one place, helping women better understand how...
MADISON, Wis., June 16, 2026 /PRNewswire/ -- WPS, A Health Solutions Company, today announced the acquisition of Mavida Health, a digital...
SAFEMOM study finds Ada improved safe and appropriate health-seeking behavior among pregnant women and mothers in South Africa, with the...
Harvard neuroscientist tells the D.C. Circuit that expanding marijuana access without fully addressing documented public health risks could have far...
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction...
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat...
— Growing body of ORLADEYO® clinical data and real-world evidence demonstrates consistent reductions in HAE attack burden and healthcare utilization...
The inaugural list of the most significant consumer technology companies announced at SXSW LondonLONDON, June 11, 2026 /PRNewswire/ -- Flo...
– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial –...
Findings from 13 different studies analyzing 730 subjects to date in 2026 across multiple geographies underscore utility of OGM in...